MHRA-101725-PIP01-24

Key Facts

Active Substance
Active Substance:
  • GUSELKUMAB
Invented Name
  • TREMFYA
  • TREMFYA
  • TREMFYA
  • TREMFYA
  • TREMFYA
PIP Number MHRA-101725-PIP01-24
Pharmaceutical form(s)
Pharmaceutical form(s):
  • Solution for injection
Therapeutic area
Therapeutic area:
  • Immunology -Rheumatology-Transplantation
Conditions / Indications
Conditions / Indications:
  • Treatment of psoriasis
Route(s) of administration
Route(s) of administration:
  • Subcutaneous use
PIP applicant
Decision Type
Decision Type
PM: decision on the application for modification of an agreed paediatric investigation plan.
Compliance Check
Compliance Check
Yes
Compliance Check Decision Date
Compliance opinion date
09/01/2025
Compliance Check Procedure Number
Compliance procedure number
MHRA-101725-PIP01-24-C

Decision Document

Decision Document Decision Document on a Paediatric Investigation Plan (PIP):GUSELKUMAB.pdf
Published Date 10/03/2025